| __timestamp | HUTCHMED (China) Limited | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 52602000 |
| Thursday, January 1, 2015 | 67426000 | 105812000 |
| Friday, January 1, 2016 | 59752000 | 113485000 |
| Sunday, January 1, 2017 | 65383000 | 285461000 |
| Monday, January 1, 2018 | 70165000 | 141726000 |
| Tuesday, January 1, 2019 | 44738000 | 150446000 |
| Wednesday, January 1, 2020 | 39457000 | 224227000 |
| Friday, January 1, 2021 | 97894000 | 361897000 |
| Saturday, January 1, 2022 | 115306000 | 520812000 |
| Sunday, January 1, 2023 | 453552000 | 636892000 |
| Monday, January 1, 2024 | 855907000 |
Cracking the code
In the ever-evolving biotech landscape, Halozyme Therapeutics, Inc. and HUTCHMED (China) Limited have showcased intriguing trajectories in gross profit over the past decade. From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, peaking at approximately $637 million in 2023. This remarkable growth underscores Halozyme's strategic advancements and market adaptability.
Conversely, HUTCHMED's journey, while impressive, reflects a more modest growth of around 2,200% during the same period, culminating in a gross profit of about $454 million in 2023. This growth trajectory highlights HUTCHMED's steady expansion in the competitive biotech sector.
The data reveals a compelling narrative of innovation and resilience, with both companies navigating the complexities of the global market. As these biotechs continue to evolve, their financial performance offers valuable insights into their strategic directions and market positions.
Gross Profit Trends Compared: Johnson & Johnson vs Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Biogen Inc. vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Genmab A/S and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Walgreens Boots Alliance, Inc. and Halozyme Therapeutics, Inc. Trends
Halozyme Therapeutics, Inc. and MorphoSys AG: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Gross Profit Trends Compared: Alkermes plc vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.